Expert Opinion On Biological Therapy

The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset

Maintaining consistent quality and clinical performance of biopharmaceuticals

Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system.

Immune checkpoint inhibition for the treatment of mesothelioma

An update on therapies for the treatment of diabetes-induced osteoporosis

Combining cell and gene therapy to advance cardiac regeneration

Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence

Poxvirus oncolytic virotherapy

Stargardt macular dystrophy and evolving therapies

Monoclonal antibodies for the prevention of migraine